Activist 13D/13G Filings - Kynam Capital Management LP

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime		TypeCompany
Symbol		Filed By
Symbol		Shares Owned
% Owned		Shares Vs. Prev ReportFiling
2024-11-14
12:29 pm
Purchase		13GBurning Rock Biotech Limited
BNR		Kynam Capital Management LP989,217
12.020%		119,774increase
(+13.78%)		View
2024-11-14
12:24 pm
Purchase		13GCogent Biosciences, Inc.
COGT		Kynam Capital Management LP9,239,731
8.360%		3,384,965increase
(+57.82%)		View
2024-11-14
12:18 pm
Purchase		13GDynavax Technologies Corporation
DVAX		Kynam Capital Management LP8,332,687
6.340%		8,332,687increase
(New Position)		View
2024-11-14
12:15 pm
Sale		13GVera Therapeutics, Inc.
VERA		Kynam Capital Management LP1,576,549
2.490%		-2,073,790decrease
(-56.81%)		View
2024-03-08
3:58 pm
Purchase		13GMorphoSys AG
MOR		Kynam Capital Management LP4,190,331
11.130%		500,000increase
(+13.55%)		View
2024-02-14
12:53 pm
Sale		13GOlema Pharmaceuticals, Inc.
OLMA		Kynam Capital Management LP0
0.000%		-2,025,234decrease
(Position Closed)		View
2024-02-14
12:52 pm
Purchase		13GCelldex Therapeutics, Inc.
CLDX		Kynam Capital Management LP3,005,904
5.500%		3,005,904increase
(New Position)		View
2024-02-14
12:51 pm
Purchase		13GCogent Biosciences, Inc.
COGT		Kynam Capital Management LP5,854,766
6.800%		5,854,766increase
(New Position)		View
2024-02-14
12:50 pm
Purchase		13GSyndax Pharmaceuticals, Inc.
SNDX		Kynam Capital Management LP5,660,000
6.670%		5,660,000increase
(New Position)		View
2024-02-14
12:49 pm
Purchase		13GVera Therapeutics, Inc.
VERA		Kynam Capital Management LP3,650,339
8.220%		2,241,241increase
(+159.06%)		View
2024-02-14
12:47 pm
Purchase		13GMorphoSys AG
MOR		Kynam Capital Management LP3,690,331
9.800%		3,690,331increase
(New Position)		View
2024-02-14
12:45 pm
Unchanged		13GBurning Rock Biotech Limited
BNR		Kynam Capital Management LP869,443
10.190%		0
(Unchanged)		View
2024-01-10
4:08 pm
Purchase		13GBurning Rock Biotech Limited
BNR		Kynam Capital Management LP869,443
10.190%		130,285increase
(+17.63%)		View
2023-09-06
4:54 pm
Purchase		13G2seventy bio, Inc.
TSVT		Kynam Capital Management LP5,953,825
11.700%		5,953,825increase
(New Position)		View
2023-03-21
5:40 pm
Sale		13GOlema Pharmaceuticals, Inc.
OLMA		Kynam Capital Management LP2,025,234
5.000%		-38,398,598decrease
(-94.99%)		View
2023-02-13
09:25 am
Unchanged		13GConcert Pharmaceuticals, Inc.
CNCE		Kynam Capital Management LP4,420,349
9.200%		0
(Unchanged)		View
2023-02-10
3:51 pm
Purchase		13GConcert Pharmaceuticals, Inc.
CNCE		Kynam Capital Management LP4,420,349
9.200%		4,420,349increase
(New Position)		View
2023-02-10
1:20 pm
Purchase		13GVera Therapeutics, Inc.
VERA		Kynam Capital Management LP1,409,098
5.100%		1,409,098increase
(New Position)		View
2023-02-10
1:18 pm
Purchase		13GOlema Pharmaceuticals, Inc.
OLMA		Kynam Capital Management LP40,423,832
5.000%		40,423,832increase
(New Position)		View
2023-02-10
1:16 pm
Purchase		13GBurning Rock Biotech Limited
BNR		Kynam Capital Management LP739,158
8.400%		739,158increase
(New Position)		View